Literature DB >> 15977241

Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China.

Youchun Wang1, Xiouhua Li, Aijing Song, Chuntao Zhang, Ying Chen, Changrong Chen, Yisheng Lin, Liping Shun, Luilan Li, Yanchun Liu, Jian Yang, Bowei Yang, Qiouping Tang, Tim J Harrison.   

Abstract

A total of 145,293 serum samples were collected from volunteer blood donors in 13 provinces of China and tested for anti-HTLV antibody using an ELISA licensed in China. Thirty were positive for anti-HTLV by ELISA and 19 of those 30 samples were confirmed positive using a supplemental immunoblot assay. Anti-HTLV-I was detected only in samples from Fujian province (a Southern province) where the positivity rate was approximately 0.05%. The region encoding gp46 from 5 of the 19 antibody positive samples was amplified and sequenced. Sequence analysis indicated that these isolates belong to HTLV-I genotype A. These data suggest that HTLV-I is not endemic throughout China and the virus may be restricted to a particular region. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977241     DOI: 10.1002/jmv.20405

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12.

Authors:  Jianhui Nie; Juan Zhao; Qingqing Chen; Weijin Huang; Youchun Wang
Journal:  Virol Sin       Date:  2014-09-28       Impact factor: 4.327

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

3.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

4.  Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China.

Authors:  Yunyun Ma; Shangen Zheng; Na Wang; Yu Duan; Xinyu Sun; Jing Jin; Wenqiao Zang; Min Li; Yuanyuan Wang; Guoqiang Zhao
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.

Authors:  Jinzhen Xie; Shengxiang Ge; Yali Zhang; Yongcai Lin; Hongying Ni; Jun Zhang; Changrong Chen
Journal:  PLoS Negl Trop Dis       Date:  2015-04-01

Review 6.  The Impact of Emerging Infectious Diseases on Chinese Blood Safety.

Authors:  Miao He; Jingxing Wang; Limin Chen; Jing Liu; Peibin Zeng
Journal:  Transfus Med Rev       Date:  2016-11-04

7.  Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.

Authors:  Le Chang; Shanhai Ou; Zhengang Shan; Faming Zhu; Huimin Ji; Xia Rong; Fei Guo; Xinyi Jiang; Huizhen Sun; Ying Yan; Lunan Wang
Journal:  Retrovirology       Date:  2021-01-07       Impact factor: 4.602

8.  Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic Japan.

Authors:  Masashi Otani; Noritaka Honda; Pin-Cang Xia; Katsuyuki Eguchi; Tatsuki Ichikawa; Toshiki Watanabe; Kazunari Yamaguchi; Kazuhiko Nakao; Taro Yamamoto
Journal:  Trop Med Health       Date:  2012-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.